4//SEC Filing
GOODMAN JONATHAN R. 4
Accession 0001104659-22-068514
CIK 0001811764other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:05 PM ET
Size
5.3 KB
Accession
0001104659-22-068514
Insider Transaction Report
Form 4
GOODMAN JONATHAN R.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 totalExercise: $8.31Exp: 2028-06-02→ Common Stock (25,614 underlying)
Footnotes (1)
- [F1]The option will vest 100% on the first anniversary of the grant date.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868590
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:05 PM ET
- Size
- 5.3 KB